DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
(+)-EPICATECHIN
2
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne; Prediabetic State; Friedreich Ataxia; Hypertension
Unknown
(+)-EPICATECHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
LD6B6TT8Q5
Molecule Type:
Small molecule
Molecular Formula:
C15H14O6
Molecular Weight:
290.27
AlogP:
1.55
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
CAT-203
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
CAT-203
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIGONELLAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Hyperlipidemias
Unknown
TRIGONELLAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
UM47085BXC
Molecule Type:
Small molecule
Molecular Formula:
C7H9N2O+
Molecular Weight:
137.16
AlogP:
-0.39
PSA:
46.97
HBD:
1.0
HBA:
#RotB:
1.0
Source:
Z160
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic; Radiculopathy
Voltage-gated N-type calcium channel alpha-1B subunit blocker
Z160
×
Maximum Phase:
2
First Approval:
None
UNII:
TX3R141LEP
Molecule Type:
Small molecule
Molecular Formula:
C32H32N2O
Molecular Weight:
460.62
AlogP:
6.14
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
7.0
Source:
RELMAPIRAZIN
2
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury
Unknown
RELMAPIRAZIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Q3UQB8PQ6H
Molecule Type:
Small molecule
Molecular Formula:
C12H16N6O8
Molecular Weight:
372.29
AlogP:
-4.01
PSA:
251.08
HBD:
8.0
HBA:
#RotB:
8.0
Source:
NT-501
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NT-501
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRU-015
2
Unknown
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic; Lymphoma; Arthritis, Rheumatoid
B-lymphocyte antigen CD20 binding agent
TRU-015
×
Maximum Phase:
2
First Approval:
None
UNII:
T0N62K2M2Y
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIBINETIDE
2
Protein
Investigational
Unknown
Unknown
Depressive Disorder
Unknown
CIBINETIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
9W5677JKDA
Molecule Type:
Protein
Molecular Formula:
C51H84N16O21
Molecular Weight:
1257.32
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RECIFERCEPT
2
Protein
Investigational
Unknown
Unknown
Achondroplasia
Unknown
RECIFERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZAGOTENEMAB
2
Antibody
Investigational
Unknown
Unknown
Alzheimer Disease
Microtubule-associated protein tau inhibitor
ZAGOTENEMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
AY6V5E2GNX
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISTIRATUMAB
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Pancreatic Neoplasms
Insulin-like growth factor I receptor inhibitor
ISTIRATUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
XLR461MD3M
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORTATAXEL
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Renal Cell; Glioblastoma; Kidney Neoplasms; Lung Neoplasms; Lymphoma
Unknown
ORTATAXEL
×
Maximum Phase:
2
First Approval:
None
UNII:
8H61Y4E29N
Molecule Type:
Small molecule
Molecular Formula:
C44H57NO17
Molecular Weight:
871.93
AlogP:
3.66
PSA:
245.82
HBD:
3.0
HBA:
#RotB:
10.0
Source:
FGF401
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Fibroblast growth factor receptor 4 inhibitor
FGF401
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PM-00104
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Endometrial Neoplasms; Uterine Cervical Neoplasms
Unknown
PM-00104
×
Maximum Phase:
2
First Approval:
None
UNII:
C21EZR41AY
Molecule Type:
Small molecule
Molecular Formula:
C37H38F3N3O8
Molecular Weight:
709.72
AlogP:
4.72
PSA:
130.03
HBD:
3.0
HBA:
#RotB:
6.0
Source:
MOXAVERINE
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases; Ischemia
Unknown
MOXAVERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
P3P08Y1XJ4
Molecule Type:
Small molecule
Molecular Formula:
C20H21NO2
Molecular Weight:
307.39
AlogP:
4.41
PSA:
31.35
HBD:
0.0
HBA:
#RotB:
5.0
Source:
NRX194204
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NRX194204
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DS107G
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DS107G
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APILIMOD MESYLATE
2
Unknown
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Crohn Disease
1-phosphatidylinositol 3-phosphate 5-kinase inhibitor
APILIMOD MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5G3P5OK11S
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MERIMEPODIB
2
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Inosine-5'-monophosphate dehydrogenase 1 inhibitor
MERIMEPODIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2ZL2BA06FU
Molecule Type:
Small molecule
Molecular Formula:
C23H24N4O6
Molecular Weight:
452.47
AlogP:
4.01
PSA:
123.95
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DORAMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis
MAP kinase p38 alpha inhibitor
DORAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
HO1A8B3YVV
Molecule Type:
Small molecule
Molecular Formula:
C31H37N5O3
Molecular Weight:
527.67
AlogP:
5.99
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TAT
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-0812
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Multiple Sclerosis, Relapsing-Remitting
C-C chemokine receptor type 2 antagonist
MK-0812
×
Maximum Phase:
2
First Approval:
None
UNII:
P3LKY4ZL5O
Molecule Type:
Small molecule
Molecular Formula:
C24H36F3N3O2
Molecular Weight:
455.57
AlogP:
4.05
PSA:
46.62
HBD:
1.0
HBA:
#RotB:
6.0
Source:
LADEMIRSEN
2
Oligonucleotide
Investigational
Unknown
Unknown
Unknown
microRNA 21 antisense inhibitor
LADEMIRSEN
×
Maximum Phase:
2
First Approval:
None
UNII:
KKQ6AQN9LH
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD0328
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
AZD0328
×
Maximum Phase:
2
First Approval:
None
UNII:
2B218X5QIY
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2O
Molecular Weight:
216.28
AlogP:
1.48
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
0.0
Source:
BALICATIB
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis; Osteoporosis
Cathepsin K inhibitor
BALICATIB
×
Maximum Phase:
2
First Approval:
None
UNII:
E00MVC7O57
Molecule Type:
Small molecule
Molecular Formula:
C23H33N5O2
Molecular Weight:
411.55
AlogP:
2.29
PSA:
88.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BPN-14770
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14770
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARBACLOFEN PLACARBIL
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Back Pain; Gastroesophageal Reflux; Muscle Spasticity; Multiple Sclerosis
GABA-B receptor agonist
ARBACLOFEN PLACARBIL
×
Maximum Phase:
2
First Approval:
None
UNII:
W89H91R7VX
Molecule Type:
Small molecule
Molecular Formula:
C19H26ClNO6
Molecular Weight:
399.87
AlogP:
3.81
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
9.0
Source:
TEBENTAFUSP
2
Protein
Investigational
Unknown
Unknown
Melanoma
Melanocyte protein PMEL binding agent
TEBENTAFUSP
×
Maximum Phase:
2
First Approval:
None
UNII:
N658GY6L3E
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONFEKAFUSP ALFA
2
Protein
Investigational
Unknown
Unknown
Glioblastoma; Glioma; Sarcoma
Unknown
ONFEKAFUSP ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
6HXC0O6JMV
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVN-944
2
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
AVN-944
×
Maximum Phase:
2
First Approval:
None
UNII:
I3NPL1V48Q
Molecule Type:
Small molecule
Molecular Formula:
C25H27N5O5
Molecular Weight:
477.52
AlogP:
5.47
PSA:
138.51
HBD:
3.0
HBA:
#RotB:
9.0
Source:
ACALISIB
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
PI3-kinase p110-delta subunit inhibitor
ACALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
OVW60IDW1D
Molecule Type:
Small molecule
Molecular Formula:
C21H16FN7O
Molecular Weight:
401.41
AlogP:
3.36
PSA:
101.38
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PARTHENOLIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PARTHENOLIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
2RDB26I5ZB
Molecule Type:
Small molecule
Molecular Formula:
C15H20O3
Molecular Weight:
248.32
AlogP:
2.76
PSA:
38.83
HBD:
0.0
HBA:
#RotB:
0.0
Source:
AG0302-COVID19
2
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
AG0302-COVID19
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMX-010
2
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Acne Vulgaris; Dermatitis, Atopic; Psoriasis; Rosacea
Unknown
BMX-010
×
Maximum Phase:
2
First Approval:
None
UNII:
BN93L2NT5I
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SOVAPREVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Hepatitis C virus serine protease, NS3/NS4A inhibitor
SOVAPREVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
2ND9V3MN6O
Molecule Type:
Small molecule
Molecular Formula:
C43H53N5O8S
Molecular Weight:
799.99
AlogP:
4.99
PSA:
164.31
HBD:
2.0
HBA:
#RotB:
13.0
Source:
1
2
…
140
141
142
143
144
145
146
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA